B vitamins for the prevention of vascular disease - Insufficient evidence to justify treatment

被引：8

作者：

Baigent, Colin

Clarke, Robert

机构：

[1] Univ Oxford, Clin Trial Serv Unit, Oxford, England

[2] Univ Oxford, Epidemiol Studies Unit, Oxford, England

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2007年 / 298卷 / 10期

关键词：

D O I：

10.1001/jama.298.10.1212

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1212 / 1214

页数：3

共 16 条

[1]

BAKER F, 2002, CIRCULATION S2, V106, P2

[2] Effect of folic acid supplementation on risk of cardiovascular diseases - A meta-analysis of randomized controlled trials [J].

Bazzano, Lydia A. ;

Reynolds, Kristi ;

Holder, Kevin N. ;

He, Jiang .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (22) :2720-2726

[3] Homocysteine lowering and cardiovascular events after acute myocardial infarction [J].

Bonaa, KH ;

Njolstad, I ;

Ueland, PM ;

Schirmer, H ;

Tverdal, A ;

Steigen, T ;

Wang, H ;

Nordrehaug, JE ;

Arnesen, E ;

Rasmussen, K .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (15) :1578-1588

[4] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].

BOUSHEY, CJ ;

BERESFORD, SAA ;

OMENN, GS ;

MOTULSKY, AG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057

[5]

Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5

[6] Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials [J].

Clarke, R ;

Armitage, J ;

Lewington, S ;

Sherliker, P ;

Collins, R ;

Brown, M ;

Blackwood, S ;

Bostom, A ;

Loan, E ;

Yusuf, S ;

Genest, J ;

Bonaa, K ;

Njolstad, I ;

Mennen, L ;

Galan, P ;

Hercberg, S ;

Jamison, R ;

Gaziano, JM ;

Hartigan, P ;

Hankey, G ;

Eikelboom, J ;

Toole, J ;

Malinow, MR ;

Chambless, LE ;

Spence, JD ;

Pettigrew, L ;

Howard, VJ ;

Sides, EG ;

Wang, CH ;

Stampfer, M ;

Manson, JE ;

Nygard, O ;

Nordrehaug, JE ;

Nilsen, DWT ;

Refsum, H ;

Ueland, PM ;

Vollset, SE .

AMERICAN HEART JOURNAL, 2006, 151 (02) :282-287

[7] Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis [J].

Clarke, R ;

Collins, R ;

Lewington, S ;

Donald, A ;

Alfthan, G ;

Tuomilehto, J ;

Arnesen, E ;

Bonaa, K ;

Blacher, J ;

Boers, GHJ ;

Bostom, A ;

Bots, ML ;

Grobee, DE ;

Brattström, L ;

Breteler, MMB ;

Hofman, A ;

Chambers, JC ;

Kooner, JS ;

Coull, BM ;

Evans, RW ;

Kuller, LH ;

Evers, S ;

Folsom, AR ;

Freyburger, G ;

Parrot, F ;

Genst, J ;

Dalery, K ;

Graham, IM ;

Daly, L ;

Hoogeveen, EK ;

Kostense, PJ ;

Stehouwer, CDA ;

Hopknis, PN ;

Jacques, P ;

Selhub, J ;

Luft, FC ;

Jungers, P ;

Lindgren, A ;

Lolin, YI ;

Loehrer, F ;

Fowler, B ;

Mansoor, MA ;

Malinow, MR ;

Ducimetiere, P ;

Nygard, O ;

Refsum, H ;

Vollset, SE ;

Ueland, PM ;

Omenn, GS ;

Beresford, SAA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2015-2022

[8]

Danesh J, 1998, J Cardiovasc Risk, V5, P229, DOI 10.1097/00043798-199808000-00004

[9] Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease - A randomized controlled trial [J].

Jamison, Rex L. ;

Hartigan, Pamela ;

Kaufman, James S. ;

Goldfarb, David S. ;

Warren, Stuart R. ;

Guarino, Peter D. ;

Gaziano, J. Michael .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10) :1163-1170

[10] MTHFR 677C→T polymorphism and risk of coronary heart disease -: A meta-analysis [J].

Klerk, M ;

Verhoef, P ;

Clarke, R ;

Blom, HJ ;

Kok, FJ ;

Schouten, EG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2023-2031

← 1 2 →